Vanda Pharmaceuticals Inc (VNDA) support and resistance · rev $102.2M
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
This page maps Vanda Pharmaceuticals Inc (VNDA) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
VNDA currently screens at market cap $358.4M. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new VNDA 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the VNDA quote page for the session range and the stock page for the full model.
Not investment advice.